%0 Journal Article
%T Established amyloid-¦Â pathology is unaffected by chronic treatment with the selective serotonin reuptake inhibitor paroxetine
%A Alicia A. Babcock
%A Asif Manzoor Khan
%A Athanasios Metaxas
%A Christian U. von Linstow
%A Elena V. Bouzinova
%A Jan Bert Gramsbergen
%A Kate L. Lambertsen
%A Louise £¿. Olesen
%A Maurizio Severino
%A Mithula Sivasaravanaparan
%A Ove Wiborg
%J Archive of "Alzheimer's & Dementia : Translational Research & Clinical Interventions".
%D 2018
%R 10.1016/j.trci.2018.04.005
%X Treatment with selective serotonin reuptake inhibitors has been suggested to mitigate amyloid-¦Â (A¦Â) pathology in Alzheimer's disease, in addition to an antidepressant mechanism of action
%K Alzheimer's disease
%K Cerebral amyloidosis
%K Neocortex
%K Monoamine
%K Serotonin
%K Selective serotonin reuptake inhibitor
%K SERT occupancy
%K [3H]DASB
%K Autoradiography
%K Transgenic mouse model
%K 5
%K 7-dihydroxytryptamine
%K Stereology
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021554/